Yousif Capital Management LLC trimmed its stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 6.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 151,735 shares of the financial services provider's stock after selling 9,968 shares during the quarter. Yousif Capital Management LLC's holdings in Aflac were worth $16,871,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Whipplewood Advisors LLC acquired a new position in Aflac during the fourth quarter worth about $26,000. BankPlus Trust Department acquired a new stake in shares of Aflac during the 4th quarter worth approximately $34,000. Curio Wealth LLC acquired a new stake in shares of Aflac during the 4th quarter worth approximately $36,000. OFI Invest Asset Management bought a new position in Aflac during the 4th quarter valued at $38,000. Finally, Capital A Wealth Management LLC bought a new position in Aflac during the 4th quarter valued at $38,000. Institutional investors and hedge funds own 67.44% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on AFL shares. Barclays lifted their price objective on Aflac from $95.00 to $96.00 and gave the stock an "underweight" rating in a report on Thursday, May 1st. Morgan Stanley increased their price objective on Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a research note on Monday, May 19th. JPMorgan Chase & Co. upped their target price on Aflac from $94.00 to $96.00 and gave the company a "neutral" rating in a report on Wednesday, April 2nd. Raymond James reduced their price target on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a report on Thursday, May 29th. Finally, UBS Group boosted their price target on Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a research note on Wednesday, April 2nd. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, Aflac currently has an average rating of "Hold" and a consensus price target of $104.93.
Read Our Latest Analysis on AFL
Insider Activity
In other Aflac news, Director Arthur Reginald Collins sold 2,750 shares of the company's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the sale, the director now owns 6,728 shares in the company, valued at $711,149.60. This represents a 29.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the transaction, the director now directly owns 26,096 shares of the company's stock, valued at approximately $2,786,791.84. This represents a 3.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 40,750 shares of company stock valued at $4,304,295 in the last quarter. Insiders own 0.90% of the company's stock.
Aflac Price Performance
Shares of AFL traded down $0.57 during trading hours on Friday, hitting $102.06. 2,259,291 shares of the stock were exchanged, compared to its average volume of 2,112,624. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. Aflac Incorporated has a 12-month low of $86.46 and a 12-month high of $115.50. The company has a market cap of $55.18 billion, a price-to-earnings ratio of 10.63, a price-to-earnings-growth ratio of 3.24 and a beta of 0.82. The stock's 50-day moving average price is $105.04 and its two-hundred day moving average price is $105.68.
Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The company had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. Aflac had a return on equity of 16.20% and a net margin of 28.76%. The business's quarterly revenue was down 37.5% on a year-over-year basis. During the same period last year, the firm posted $1.66 EPS. Research analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were paid a $0.58 dividend. This represents a $2.32 annualized dividend and a dividend yield of 2.27%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac's dividend payout ratio (DPR) is presently 36.25%.
About Aflac
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also

Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.